Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2 values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.
1 January 2020 in Research Journal of Pharmacy and Technology
Tadalafil has low solubility and low oral bioavailability, so it's a challenge to formulate suitable dosage form. In this Present investigation to enhance the dissolution rate and solubility skimmed milk is used as a carrier. Physical mixers were prepared using various drugs to carrier ratio. Material and Methods: Spry drying technology was used to prepared solid dispersion of drug with skimmed milk. Various techniques were used to characterize the solid dispersion immediately after they were made which includes Differential scanning calorimetry, fourier transform infrared spectroscopy, X-ray diffraction and in-vitro dissolution profiles. Results: The Differential Scanning Calorimetry thermograms of raw drug indicated of its anhydrous crystalline nature. In thermograms of solid dispersion, the characteristic peak was absent suggesting the change from crystalline nature to amorphous form. X-ray diffraction confirmed the results. The results of raw drug showed highly extreme peak characteristic of its crystalline nature where solid dispersion showed less intense, more diffused peak indicating the change in crystalline form. Fourier transform infrared spectroscopy studies indicated between drug and carrier there were no interaction. The whole formulation showed distinct enhancement in the drug release behavior and solubility. Conclusion: The optimum drug to carrier ratio 1:10 enhance the solubility and in-vitro drug release also increase by 3 fold. For improvement of drug release and solubility, it was concluded that as a carrier skimmed milk powder can be utilized very well.